Page 14 - String Technologies News Today

Wall Street analysts expect that NanoString Technologies, Inc. (NASDAQ:NSTG – Get Rating) will report $32.40 million in sales for the current quarter, Zacks Investment Research reports. Three analysts have provided estimates for NanoString Technologies’ earnings, with the lowest sales estimate coming in at $32.10 million and the highest estimate coming in at $32.62 million. NanoString […]

Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.

Brokerages expect NanoString Technologies, Inc. (NASDAQ:NSTG – Get Rating) to announce earnings per share of ($0.67) for the current fiscal quarter, according to Zacks. Three analysts have provided estimates for NanoString Technologies’ earnings, with the highest EPS estimate coming in at ($0.59) and the lowest estimate coming in at ($0.76). NanoString Technologies reported earnings per […]

This lab hardware business is growing, cashed up, and close to profitability.

Worldwide Healthcare Trust Plc - Audited Results for the year ended 31 March 2022 PR Newswire London, May 27 LONDON STOCK EXCHANGE ANNOUNCEMENT Worldwide Healthcare

DUBLIN--(BUSINESS WIRE)--The "Circulating Tumor Cell Market Research Report by Specimen (Blood, Bone Marrow, and Other Body Fluids), Technology, Product, Application, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com's offering. The Global Circulating Tumor…

The "Circulating Tumor Cell Market Research Report by Specimen (Blood, Bone Marrow, and Other Body Fluids), Technology, Product, Application, Region (Americas, Asia-Pacific, and Europe, Middle East Africa)

Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.

Vir Biotechnology (NASDAQ:VIR – Get Rating) and NanoString Technologies (NASDAQ:NSTG – Get Rating) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, profitability, risk, valuation, earnings, institutional ownership and dividends. Risk & Volatility Vir Biotechnology has a beta of -0.97, […]

NanoString Technologies (NASDAQ:NSTG – Get Rating) had its price objective dropped by Robert W. Baird from $51.00 to $35.00 in a report released on Wednesday, The Fly reports. Robert W. Baird’s target price points to a potential upside of 58.30% from the company’s current price. A number of other brokerages also recently issued reports on […]